STOCK TITAN

CSCO insider files Form 144 to sell 428 shares via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cisco Systems, Inc. (CSCO) filing is a Form 144 notice reporting a proposed sale of 428 common shares, with an aggregate market value of $29,159.64, to be sold on or about 09/11/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The shares were acquired as Restricted Stock Units on 09/10/2025 from the issuer and payment (if any) was recorded on 09/10/2025. The filer also disclosed two prior 10b5-1 plan sales this quarter: 3,162 shares on 08/25/2025 for $212,739.36 and 475 shares on 08/15/2025 for $32,589.75. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

  • Transparent disclosure of proposed sale details including broker, date, share count, and market value
  • Use of 10b5-1 plans for prior sales indicates pre-established trading arrangements that reduce concerns about opportunistic insider trading

Negative

  • None.

Insights

TL;DR: Routine executive share disposition; limited market impact given small size relative to outstanding shares.

This Form 144 reports a modest proposed sale of 428 shares valued at $29k, following acquisition of RSUs one day earlier. The filing also lists two recent 10b5-1 sales totaling 3,637 shares and roughly $245k in proceeds. Given the issuer's reported outstanding share count of 3,953,196,953, these transactions are immaterial to overall float and likely reflect routine executive liquidity rather than a corporate development. Disclosure complies with Rule 144 mechanics and 10b5-1 plan reporting.

TL;DR: Compliance-focused disclosure; shows use of 10b5-1 plans and RSU monetization by an insider.

The notice documents sale execution through a brokerage and affirms the seller's representation about material non-public information. Reporting of RSU acquisition and near-term sale is transparent and consistent with standard governance practices. The amounts and timing suggest planned liquidity events rather than abrupt insider dispositions, supporting a neutral governance signal.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Cisco's (CSCO) Form 144 filed here report?

The Form 144 reports a proposed sale of 428 common shares valued at $29,159.64 to be sold on or about 09/11/2025 through Morgan Stanley Smith Barney LLC on NASDAQ.

When were the shares being sold acquired according to the filing?

The filing shows the shares were acquired as Restricted Stock Units on 09/10/2025 and payment or settlement is recorded as 09/10/2025.

Did the filer sell other Cisco (CSCO) shares recently?

Yes. The filing discloses two prior 10b5-1 sales this quarter: 3,162 shares on 08/25/2025 for $212,739.36 and 475 shares on 08/15/2025 for $32,589.75.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY.

Does the filing state any undisclosed material information about Cisco (CSCO)?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.